Cargando…
Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor
Osteonecrosis is a pathological condition that could lead to a debilitating physical disease and impede daily activities. It is generally categorised into aetiology – primary (idiopathic) or secondary. When direct damage to the bone vasculature or direct injury of the bone marrow is related to an id...
Autores principales: | Haydock, Maria Monica, Elhamdani, Shahed, Alsharedi, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366292/ https://www.ncbi.nlm.nih.gov/pubmed/30783528 http://dx.doi.org/10.1177/2050313X19827747 |
Ejemplares similares
-
Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur
por: Raman, Srishty, et al.
Publicado: (2021) -
Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor‐1 and osteonecrosis risk in childhood acute lymphoblastic leukemia
por: Sherief, Laila M., et al.
Publicado: (2021) -
New horizons in anticoagulation: Direct oral
anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017) -
Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020) -
Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)